Deoxythymidine diphosphate (dTDP)-L-rhamnose is the precursor of L-rhamnose
, a saccharide required for the virulence of some pathogenic bacteria. dTDP
-L-rhamnose is synthesized from glucose-l-phosphate and deoxythymidine trip
hosphate (dTTP) via a pathway involving four distinct enzymes. This pathway
does not exist in humans and the enzymes involved in dTDP-L-rhamnose synth
esis are potential targets for the design of new therapeutic agents. Here,
the crystal structure of dTDP-6-deoxy-D-xylo-4-hexulose 3,5 epimerase (RmlC
, EC5.1.3.13) from Salmonella enterica serovar Typhimurium was determined.
The third enzyme of the rhamnose biosynthetic pathway, RmlC epimerizes at t
wo carbon centers, the 3 and 5 positions of the sugar ring. The structure w
as determined by multiwavelength anomalous diffraction to a resolution of 2
.17 Angstrom. RmlC is a dimer and each monomer is formed mainly from two be
ta-sheets arranged in a beta-sandwich. The structure of a dTDP-phenol-RmlC
complex shows the substrate-binding site to be located between the two beta
-sheets; this site is formed from residues of both monomers. Sequence align
ments of other RmlC enzymes confirm that this region is very highly conserv
ed. The enzyme is distinct structurally from other epimerases known and thu
s, is the first example of a new class of carbohydrate epimerase.